Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial

• Glavni autori: Milad Daneshi-Maskooni (Autor), Seyed Ali Keshavarz (Autor), Mostafa Qorbani (Autor), Siavash Mansouri (Autor), Seyed Moayed Alavian (Autor), Mahtab Badri-Fariman (Autor), Seyed Ali Jazayeri-Tehrani (Autor), Gity Sotoudeh (Autor)
• Format: Knjiga
• Izdano: BMC, 2019-03-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Abstract Background Despite the reported health effects of cardamom on dyslipidemia, hepatomegaly, and fasting hyperglycemia, no human research has studied its potency in non-alcoholic fatty liver disease (NAFLD) as the hepatic part of metabolic syndrome. Our aim was determining the effects of green...